Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.38 is 18% below its 5-year average of 1.68, near the low end of its 5-year range (1.10–3.23).
As of the fiscal period ended Tuesday, June 30, 2026. 9.14% below its 12-month average of 1.51.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.38.
CURRENT RATIO
1.38
CURRENT RATIO AVG TTM
1.51
CURRENT RATIO AVG 3Y
1.36
CURRENT RATIO AVG 5Y
1.68
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-9.14%
CURRENT VS 3Y AVG
+1.35%
CURRENT VS 5Y AVG
-18.20%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.74
median of 847 covered companies
CURRENT VS SECTOR MEDIAN
-63.22%
vs the sector median at left
LifeStance Health Group, Inc.
Market Cap
$4.68B
Current Ratio
1.38
TTM Avg
1.51
3Y Avg
1.36
5Y Avg
1.68
Market Cap
$4.66B
Current Ratio
6.95
TTM Avg
6.77
3Y Avg
6.23
5Y Avg
10.87
Market Cap
$4.70B
Current Ratio
26.10
TTM Avg
14.27
3Y Avg
14.23
5Y Avg
14.47
Market Cap
$4.79B
Current Ratio
38.51
TTM Avg
25.63
3Y Avg
37.00
5Y Avg
29.64
Market Cap
$4.81B
Current Ratio
2.86
TTM Avg
2.88
3Y Avg
3.29
5Y Avg
4.98
Market Cap
$4.42B
Current Ratio
5.08
TTM Avg
3.83
3Y Avg
4.06
5Y Avg
4.06
Market Cap
$4.40B
Current Ratio
0.84
TTM Avg
0.80
3Y Avg
0.95
5Y Avg
1.27
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LifeStance Health Group, Inc. (LFST) | $4.68B | 1.38 | 1.51 | 1.36 | 1.68 |
| Option Care Health, Inc. (OPCH)vs › | $4.66B | 1.47 | 1.61 | 1.69 | 1.64 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.66B | 6.95 | 6.77 | 6.23 | 10.87 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.70B | 26.10 | 14.27 | 14.23 | 14.47 |
| BillionToOne, Inc. (BLLN)vs › | $4.72B | 11.69 | 9.86 | 7.15 | 7.15 |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.79B | 38.51 | 25.63 | 37.00 | 29.64 |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.81B | 2.86 | 2.88 | 3.29 | 4.98 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.42B | 5.08 | 3.83 | 4.06 | 4.06 |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.40B | 0.84 | 0.80 | 0.95 | 1.27 |
| Erasca, Inc. (ERAS)vs › | $4.96B | 8.29 | 9.94 | 10.32 | 11.01 |
Current Ratio
1.38
Quick Ratio
1.38
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.38 |
| 2026-03-31 | 1.48 |
| 2025-12-31 | 1.65 |
| 2025-09-30 | 1.58 |
| 2025-06-30 | 1.48 |
| 2025-03-31 | 1.47 |
| 2024-12-31 | 1.37 |
| 2024-09-30 | 1.32 |
| 2024-06-30 | 1.22 |
| 2024-03-31 | 1.18 |
| 2023-12-31 | 1.11 |
| 2023-09-30 | 1.10 |
| 2023-06-30 | 1.32 |
| 2023-03-31 | 1.17 |
| 2022-12-31 | 1.33 |
| 2022-09-30 | 2.25 |
| 2022-06-30 | 2.19 |
| 2022-03-31 | 2.10 |
| 2021-12-31 | 2.28 |
| 2021-09-30 | 3.12 |
| 2021-06-30 | 3.23 |
| 2021-03-31 | 1.13 |
| 2020-12-31 | 1.00 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
